<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <billNumber>3536</billNumber>
    <committeeReports />
    <cboCostEstimates />
    <summaries>
      <billSummaries>
        <item>
          <lastSummaryUpdateDate>2019-03-19T19:09:41Z</lastSummaryUpdateDate>
          <text><![CDATA[<p>This bill prohibits federal agencies and nonprofit entities that conduct federally funded health care research from providing a patent for a drug based on such research until the entity receiving the patent enters into a reasonable pricing agreement with the Department of Health and Human Services.</p>]]></text>
          <versionCode>00</versionCode>
          <actionDate>2017-07-28</actionDate>
          <actionDesc>Introduced in House</actionDesc>
          <updateDate>2017-07-28T04:00:00Z</updateDate>
          <name>Introduced in House</name>
        </item>
      </billSummaries>
    </summaries>
    <notes />
    <createDate>2017-07-29T03:11:37Z</createDate>
    <cosponsors>
      <item>
        <bioguideId>C000714</bioguideId>
        <party>D</party>
        <sponsorshipDate>2017-09-05</sponsorshipDate>
        <sponsorshipWithdrawnDate />
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <middleName />
        <district>13</district>
        <state>MI</state>
        <fullName>Rep. Conyers, John, Jr. [D-MI-13]</fullName>
        <lastName>CONYERS</lastName>
        <firstName>JOHN</firstName>
        <identifiers>
          <bioguideId>C000714</bioguideId>
          <gpoId>7999</gpoId>
          <lisID>229</lisID>
        </identifiers>
      </item>
      <item>
        <bioguideId>S001145</bioguideId>
        <party>D</party>
        <sponsorshipDate>2017-09-05</sponsorshipDate>
        <sponsorshipWithdrawnDate />
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <middleName>D.</middleName>
        <district>9</district>
        <state>IL</state>
        <fullName>Rep. Schakowsky, Janice D. [D-IL-9]</fullName>
        <lastName>SCHAKOWSKY</lastName>
        <firstName>JANICE</firstName>
        <identifiers>
          <lisID>1588</lisID>
          <gpoId>7929</gpoId>
          <bioguideId>S001145</bioguideId>
        </identifiers>
      </item>
      <item>
        <bioguideId>K000009</bioguideId>
        <party>D</party>
        <sponsorshipDate>2017-09-05</sponsorshipDate>
        <sponsorshipWithdrawnDate />
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <middleName />
        <district>9</district>
        <state>OH</state>
        <fullName>Rep. Kaptur, Marcy [D-OH-9]</fullName>
        <lastName>KAPTUR</lastName>
        <firstName>MARCY</firstName>
        <identifiers>
          <lisID>616</lisID>
          <gpoId>8099</gpoId>
          <bioguideId>K000009</bioguideId>
        </identifiers>
      </item>
      <item>
        <bioguideId>C000984</bioguideId>
        <party>D</party>
        <sponsorshipDate>2017-09-05</sponsorshipDate>
        <sponsorshipWithdrawnDate />
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <middleName>E.</middleName>
        <district>7</district>
        <state>MD</state>
        <fullName>Rep. Cummings, Elijah E. [D-MD-7]</fullName>
        <lastName>CUMMINGS</lastName>
        <firstName>ELIJAH</firstName>
        <identifiers>
          <bioguideId>C000984</bioguideId>
          <gpoId>7982</gpoId>
          <lisID>256</lisID>
        </identifiers>
      </item>
      <item>
        <bioguideId>G000551</bioguideId>
        <party>D</party>
        <sponsorshipDate>2017-09-07</sponsorshipDate>
        <sponsorshipWithdrawnDate />
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <middleName>M.</middleName>
        <district>3</district>
        <state>AZ</state>
        <fullName>Rep. Grijalva, Raul M. [D-AZ-3]</fullName>
        <lastName>Grijalva</lastName>
        <firstName>Raul</firstName>
        <identifiers>
          <bioguideId>G000551</bioguideId>
          <lisID>1708</lisID>
          <gpoId>7804</gpoId>
        </identifiers>
      </item>
      <item>
        <bioguideId>S000480</bioguideId>
        <party>D</party>
        <sponsorshipDate>2017-11-08</sponsorshipDate>
        <sponsorshipWithdrawnDate />
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <middleName>M.</middleName>
        <district>25</district>
        <state>NY</state>
        <fullName>Rep. Slaughter, Louise McIntosh [D-NY-25]</fullName>
        <lastName>SLAUGHTER</lastName>
        <firstName>LOUISE</firstName>
        <identifiers>
          <lisID>1069</lisID>
          <gpoId>8089</gpoId>
          <bioguideId>S000480</bioguideId>
        </identifiers>
      </item>
      <item>
        <bioguideId>K000389</bioguideId>
        <party>D</party>
        <sponsorshipDate>2018-07-11</sponsorshipDate>
        <sponsorshipWithdrawnDate />
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <middleName />
        <district>17</district>
        <state>CA</state>
        <fullName>Rep. Khanna, Ro [D-CA-17]</fullName>
        <lastName>Khanna</lastName>
        <firstName>Ro</firstName>
        <identifiers>
          <bioguideId>K000389</bioguideId>
          <lisID>2308</lisID>
          <gpoId />
        </identifiers>
      </item>
    </cosponsors>
    <originChamber>House</originChamber>
    <amendments />
    <updateDate>2019-11-15T21:21:11Z</updateDate>
    <relatedBills>
      <item>
        <latestAction>
          <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
          <actionDate>2017-07-31</actionDate>
        </latestAction>
        <type>S</type>
        <relationshipDetails>
          <item>
            <type>Identical bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
        <congress>115</congress>
        <number>1681</number>
        <latestTitle>A bill to require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.</latestTitle>
      </item>
    </relatedBills>
    <latestAction>
      <text>Referred to the Subcommittee on Health.</text>
      <actionDate>2017-08-04</actionDate>
      <links />
    </latestAction>
    <introducedDate>2017-07-28</introducedDate>
    <laws />
    <subjects>
      <billSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
        <legislativeSubjects>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Health programs administration and funding</name>
          </item>
          <item>
            <name>Health technology, devices, supplies</name>
          </item>
          <item>
            <name>Inflation and prices</name>
          </item>
          <item>
            <name>Intellectual property</name>
          </item>
          <item>
            <name>Medical research</name>
          </item>
          <item>
            <name>Research and development</name>
          </item>
        </legislativeSubjects>
      </billSubjects>
    </subjects>
    <calendarNumbers />
    <textVersions>
      <item>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-115hr3536ih/xml/BILLS-115hr3536ih.xml</url>
          </item>
        </formats>
        <date>2017-07-28T04:00:00Z</date>
        <type>Introduced in House</type>
      </item>
    </textVersions>
    <version>1.0.0</version>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <recordedVotes />
    <sponsors>
      <item>
        <bioguideId>D000191</bioguideId>
        <state>OR</state>
        <party>D</party>
        <fullName>Rep. DeFazio, Peter A. [D-OR-4]</fullName>
        <firstName>PETER</firstName>
        <lastName>DEFAZIO</lastName>
        <identifiers>
          <bioguideId>D000191</bioguideId>
          <lisID>279</lisID>
          <gpoId>8117</gpoId>
        </identifiers>
        <byRequestType />
        <middleName>A.</middleName>
        <district>4</district>
      </item>
    </sponsors>
    <billType>HR</billType>
    <constitutionalAuthorityStatementText><![CDATA[<pre>[Congressional Record Volume 163, Number 128 (Friday, July 28, 2017)]From the Congressional Record Online through the Government Publishing Office [<a href='http://www.gpo.gov'>www.gpo.gov</a>]By Mr. DeFAZIO:H.R. 3536.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 18 (relating to the power tomake all laws necessary and proper for carrying out thepowers vested in Congress)[Page H6577]</pre>]]></constitutionalAuthorityStatementText>
    <title>To require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.</title>
    <congress>115</congress>
    <committees>
      <billCommittees>
        <item>
          <chamber>House</chamber>
          <subcommittees>
            <item>
              <activities>
                <item>
                  <name>Referred to</name>
                  <date>2017-08-04T15:02:01Z</date>
                </item>
              </activities>
              <systemCode>hsif14</systemCode>
              <name>Health Subcommittee</name>
            </item>
          </subcommittees>
          <type>Standing</type>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2017-07-28T13:07:45Z</date>
            </item>
          </activities>
          <name>Energy and Commerce Committee</name>
          <systemCode>hsif00</systemCode>
        </item>
      </billCommittees>
    </committees>
    <actions>
      <actionByCounts>
        <houseOfRepresentatives>4</houseOfRepresentatives>
      </actionByCounts>
      <item>
        <actionDate>2017-08-04</actionDate>
        <committee>
          <name>Health Subcommittee</name>
          <systemCode>hsif14</systemCode>
        </committee>
        <links />
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2017-07-28</actionDate>
        <committee>
          <name>Energy and Commerce Committee</name>
          <systemCode>hsif00</systemCode>
        </committee>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <links />
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <text>Referred to the House Committee on Energy and Commerce.</text>
      </item>
      <item>
        <actionDate>2017-07-28</actionDate>
        <committee />
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <links />
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <text>Introduced in House</text>
      </item>
      <item>
        <actionDate>2017-07-28</actionDate>
        <committee />
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <links />
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <text>Introduced in House</text>
      </item>
      <actionTypeCounts>
        <introducedInTheHouse>1</introducedInTheHouse>
        <introducedInHouse>1</introducedInHouse>
        <placeholderTextForH>1</placeholderTextForH>
        <billReferrals>1</billReferrals>
      </actionTypeCounts>
    </actions>
    <titles>
      <item>
        <chamberName />
        <title>To require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.</title>
        <parentTitleType />
        <titleType>Official Title as Introduced</titleType>
        <chamberCode />
      </item>
      <item>
        <chamberName />
        <title>To require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.</title>
        <parentTitleType />
        <titleType>Display Title</titleType>
        <chamberCode />
      </item>
    </titles>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

